{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:07:56Z","timestamp":1790712476399,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273537"],"award-info":[{"award-number":["82273537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404121"],"award-info":[{"award-number":["82404121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Psoriasis is an immune-mediated disorder whose recurrence is primarily driven by cutaneous-resident T cells. Cutaneous T cells produce high levels of pathogenic cytokines, which subsequently initiate and sustain hyperproliferation and aberrant inflammatory cascades in keratinocytes. However, how keratinocytes orchestrate the activities of the cutaneous T cells remains elusive. Herein, single-cell RNA-sequencing and multiplex immunohistochemistry staining revealed that psoriatic keratinocytes upregulated the expression of T cell co-stimulator inducible T cell co-stimulator ligand (ICOSLG) and RUNX1, which showed a positive correlation. Multiplex immunohistochemistry further proved that ICOSLG colocalized with ICOS on T cell surfaces within psoriasis lesions, indicating that the ICOSLG\u2013ICOS signal mediated keratinocyte-dependent T cell activation in psoriatic inflammation. Mechanistic investigations showed that RUNX1 transcriptionally upregulated ICOSLG expression via recruiting GCN5 (general control non-derepressible 5) to ICOSLG promoter, and the GCN5 inhibitor butyrolactone 3 (MB-3) reduced ICOSLG expression in keratinocytes. In a mouse model of psoriasis, MB-3 treatment ameliorated imiquimod-induced psoriatic lesion and its recurrence by suppressing keratinocyte ICOSLG expression and subsequent T cell activation. Notably, our keratinocyte-specific GCN5 knockdown mouse model demonstrated that this genetic ablation impaired the therapeutic benefits of MB-3. Taken together, these findings uncover the molecular mechanism driving ICOSLG upregulation in keratinocytes. Our study supports that clinical evaluation of the GCN5 inhibitor MB-3 is warranted for patients with psoriasis with ICOSLG overexpression.<\/jats:p>","DOI":"10.1038\/s12276-026-01738-8","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:50:50Z","timestamp":1780545050000},"page":"1838-1853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RUNX1 recruitment of GCN5 in keratinocytes upregulates ICOSLG and promotes T cell activation in the psoriasis microenvironment"],"prefix":"10.1038","volume":"58","author":[{"given":"Lifei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"1738_CR1","doi-asserted-by":"publisher","first-page":"13313","DOI":"10.3390\/ijms241713313","volume":"24","author":"HJ Lee","year":"2023","unstructured":"Lee, H. J. & Kim, M. Challenges and future trends in the treatment of psoriasis. Int J Mol Sci. 24, 13313 (2023).","journal-title":"Int J Mol Sci."},{"key":"1738_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke, W. H. & Schon, M. P. Psoriasis. Lancet 386, 983\u2013994 (2015).","journal-title":"Lancet"},{"key":"1738_CR3","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.jid.2018.02.030","volume":"138","author":"I Gallais Serezal","year":"2018","unstructured":"Gallais Serezal, I. et al. Resident T cells in resolved psoriasis steer tissue responses that stratify clinical outcome. J Invest Dermatol 138, 1754\u20131763 (2018).","journal-title":"J Invest Dermatol"},{"key":"1738_CR4","doi-asserted-by":"publisher","first-page":"100116","DOI":"10.1016\/j.xjidi.2022.100116","volume":"2","author":"D Tian","year":"2022","unstructured":"Tian, D. & Lai, Y. The relapse of psoriasis: mechanisms and mysteries. JID Innov 2, 100116 (2022).","journal-title":"JID Innov"},{"key":"1738_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/JLB.5MR0120-439R","volume":"108","author":"X Ni","year":"2020","unstructured":"Ni, X. & Lai, Y. Keratinocyte: a trigger or an executor of psoriasis? J Leukoc Biol 108, 485\u2013491 (2020).","journal-title":"J Leukoc Biol"},{"key":"1738_CR6","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/s41423-022-00940-8","volume":"19","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. The epidermal immune microenvironment plays a dominant role in psoriasis development, as revealed by mass cytometry. Cell Mol Immunol 19, 1400\u20131413 (2022).","journal-title":"Cell Mol Immunol"},{"key":"1738_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","volume":"131","author":"A Chiricozzi","year":"2011","unstructured":"Chiricozzi, A. et al. Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 131, 677\u2013687 (2011).","journal-title":"J Invest Dermatol"},{"key":"1738_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes, J. E., Chan, T. C. & Krueger, J. G. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol 140, 645\u2013653 (2017).","journal-title":"J Allergy Clin Immunol"},{"key":"1738_CR9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi, K., Balato, A., Enerback, C. & Sabat, R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 397, 754\u2013766 (2021).","journal-title":"Lancet"},{"key":"1738_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1126\/science.adi8885","volume":"382","author":"SL Park","year":"2023","unstructured":"Park, S. L. et al. Divergent molecular networks program functionally distinct CD8(+) skin-resident memory T cells. Science 382, 1073\u20131079 (2023).","journal-title":"Science"},{"key":"1738_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","volume":"23","author":"RJ Greenwald","year":"2005","unstructured":"Greenwald, R. J., Freeman, G. J. & Sharpe, A. H. The B7 family revisited. Annu Rev Immunol 23, 515\u2013548 (2005).","journal-title":"Annu Rev Immunol"},{"key":"1738_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.immuni.2021.11.017","volume":"55","author":"C Peng","year":"2022","unstructured":"Peng, C. et al. Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8(+) tissue-resident memory T cells. Immunity 55, 98\u2013114.e5 (2022).","journal-title":"Immunity"},{"key":"1738_CR13","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.4049\/jimmunol.164.9.4689","volume":"164","author":"A Aicher","year":"2000","unstructured":"Aicher, A. et al. Characterization of human inducible costimulator ligand expression and function. J Immunol 164, 4689\u20134696 (2000).","journal-title":"J Immunol"},{"key":"1738_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-022-04918-4","volume":"607","author":"L Garcia-Alonso","year":"2022","unstructured":"Garcia-Alonso, L. et al. Single-cell roadmap of human gonadal development. Nature 607, 540\u2013547 (2022).","journal-title":"Nature"},{"key":"1738_CR15","doi-asserted-by":"publisher","first-page":"5263","DOI":"10.4049\/jimmunol.0902464","volume":"184","author":"K Guilloteau","year":"2010","unstructured":"Guilloteau, K. et al. Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1{alpha}, and TNF-{alpha} Recapitulates Some Features of Psoriasis. J Immunol 184, 5263\u20135270 (2010).","journal-title":"J Immunol"},{"key":"1738_CR16","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.celrep.2017.08.078","volume":"20","author":"BV Kumar","year":"2017","unstructured":"Kumar, B. V. et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep 20, 2921\u20132934 (2017).","journal-title":"Cell Rep"},{"key":"1738_CR17","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. Psoriasis. Lancet 397, 1301\u20131315 (2021) .","journal-title":"Lancet"},{"key":"1738_CR18","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/intimm\/12.10.1439","volume":"12","author":"SK Yoshinaga","year":"2000","unstructured":"Yoshinaga, S. K. et al. Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int Immunol 12, 1439\u20131447 (2000).","journal-title":"Int Immunol"},{"key":"1738_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104613","volume":"25","author":"M K\u00fclp","year":"2022","unstructured":"K\u00fclp, M. et al. The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia. iScience 25, 104613 (2022).","journal-title":"iScience"},{"key":"1738_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2147\/JIR.S401123","volume":"16","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. ICOS\/ICOSLG and PD-1 co-expression is associated with the progression of colorectal precancerous-carcinoma immune microenvironment. J Inflamm Res 16, 977\u2013992 (2023).","journal-title":"J Inflamm Res"},{"key":"1738_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature24271","volume":"550","author":"S Naik","year":"2017","unstructured":"Naik, S. et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature 550, 475\u2013480 (2017).","journal-title":"Nature"},{"key":"1738_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Chen, Y., Cui, L., Shi, Y. & Guo, C. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis 13, 81 (2022).","journal-title":"Cell Death Dis"},{"key":"1738_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-981-10-3233-2_2","volume":"962","author":"TH Tahirov","year":"2017","unstructured":"Tahirov, T. H. & Bushweller, J. Structure and biophysics of CBFbeta\/RUNX and its translocation products. Adv Exp Med Biol 962, 21\u201331 (2017).","journal-title":"Adv Exp Med Biol"},{"key":"1738_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.immuni.2011.03.014","volume":"34","author":"S Yao","year":"2011","unstructured":"Yao, S. et al. B7-h2 is a costimulatory ligand for CD28 in human. Immunity 34, 729\u2013740 (2011).","journal-title":"Immunity"},{"key":"1738_CR25","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","volume":"129","author":"R Sood","year":"2017","unstructured":"Sood, R., Kamikubo, Y. & Liu, P. Role of RUNX1 in hematological malignancies. Blood 129, 2070\u20132082 (2017).","journal-title":"Blood"},{"key":"1738_CR26","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41589-019-0354-y","volume":"15","author":"M Semer","year":"2019","unstructured":"Semer, M. et al. DNA repair complex licenses acetylation of H2A.Z.1 by KAT2A during transcription. Nat Chem Biol 15, 992\u20131000 (2019).","journal-title":"Nat Chem Biol"},{"key":"1738_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41580-018-0029-7","volume":"19","author":"X Li","year":"2018","unstructured":"Li, X., Egervari, G., Wang, Y., Berger, S. L. & Lu, Z. Regulation of chromatin and gene expression by metabolic enzymes and metabolites. Nat Rev Mol Cell Biol 19, 563\u2013578 (2018).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1738_CR28","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1038\/sj.onc.1210604","volume":"26","author":"Z Nagy","year":"2007","unstructured":"Nagy, Z. & Tora, L. Distinct GCN5\/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene 26, 5341\u20135357 (2007).","journal-title":"Oncogene"},{"key":"1738_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adp8973","volume":"18","author":"DY Cho","year":"2025","unstructured":"Cho, D. Y. et al. The acetyltransferase GCN5 contributes to neuroinflammation in mice by acetylating and activating the NF-\u03baB subunit p65 in microglia. Sci Signal 18, eadp8973 (2025).","journal-title":"Sci Signal"},{"key":"1738_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1042\/CS20200986","volume":"135","author":"ME Haque","year":"2021","unstructured":"Haque, M. E. et al. The GCN5: its biological functions and therapeutic potentials. Clin Sci (Lond) 135, 231\u2013257 (2021).","journal-title":"Clin Sci (Lond)"},{"key":"1738_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.306","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Targeting KAT2A inhibits inflammatory macrophage activation and rheumatoid arthritis through epigenetic and metabolic reprogramming. MedComm 4, e306 (2023).","journal-title":"MedComm"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01738-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01738-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01738-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:56:12Z","timestamp":1782914172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01738-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1738"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01738-8","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The participants provided written consent for data publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The animal study was performed strictly according to established ARRIVE criteria 2.0 guidelines and the Principles for the Utilization and Care of Vertebrate Animals. The study was approved by the Animal Ethics Committee of Guangdong Provincial People\u2019s Hospital, Guangdong Academy of Medical Sciences (Approval No. KY2024-1186-01). Related investigations involving patient specimens have obtained approval from the Institutional Review Board of Guangdong Provincial People\u2019s Hospital (Approval No. KY2024-811-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}